ERBB2 and breast carcinoma: Generally, luminal breast cancers tend to have a lower probability of metastatic spread and the better outcomes, while HER2-positive and TNBC subtypes have a higher propensity for metastatic progression and are associated with a poorer prognosis 2, 5.